(Q35720124)

9 August 2017

1 reference

title

Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic (English)

1 reference

9 August 2017

1 reference

Joris C Verster

1

1 reference

9 August 2017

Edmund R Volkerts

series ordinal

2

1 reference

9 August 2017

language of work or name

1 reference

1 March 2004

1 reference

Annals of Allergy, Asthma & Immunology

9 August 2017

published in

1 reference

9 August 2017

volume

92

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

294-303; quiz 303-5, 355

1 reference

Allergic rhinitis and its impact on asthma

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Diazepam impairs lateral position control in highway driving.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Driving performance under the influence of drugs: rationale for, and application of, a new test

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental performance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Effects of Fexofenadine, Diphenhydramine, and Alcohol on Driving Performance: A Randomized, Placebo-Controlled Trial in the Iowa Driving Simulator

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Acute and subacute actions on human performance and interactions with diazepam of temelastine (SK&F93944) and diphenhydramine.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Cardiotoxic potential and CNS effects of first-generation antihistamines.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

The work impact of asthma and rhinitis: findings from a population-based survey

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961566-9

7 January 2021

10.1016/S1081-1206(10)61566-9

Identifiers

DOI

1 reference

9 August 2017

1 reference